The antioxidant properties of organosulfur compounds (sulforaphane).
Level 5 - mechanism / opinion, no new human data
Narrative review and patent survey with no new human data
PubMed 25944116 · doi:10.2174/1872214809666150505164138
What was done
This is a narrative review and patent survey summarizing the antioxidant, anti-inflammatory, and chemopreventive properties of sulforaphane, an isothiocyanate phytochemical found in cruciferous vegetables. The authors summarize mechanisms from cellular and animal models and review relevant intellectual property and patent applications.
What was found
The abstract reports no primary experimental data, effect sizes, or quantitative findings. Qualitatively, it reports that sulforaphane induces Phase I and Phase II detoxification enzymes, activates the Nrf2 cytoprotective pathway, inhibits cancer cell viability in a dose-dependent manner, and modulates epigenetic events in cancer cells. Several patents covering cancer therapy, adjuvant uses, glutathione promotion, and extraction techniques are cited.
Why it matters
It provides an overview of preclinical antioxidant mechanisms attributed to sulforaphane alongside a survey of therapeutic and compositional patents.
Limits
As a narrative review, it lacks systematic search criteria, quality appraisal, and primary quantitative evidence. The abstract presents no primary human clinical trial data, sample sizes, or clinical efficacy outcomes.